SkinPen

Clinically proven to reduce the appearance of acne scars, SkinPen is the first microneedling device with FDA clearance for scar management.

Recent clinical trials suggest that 90% of people trialled, aged 22 and over, with facial acne scarring said they would recommend SkinPen to family and friends.
3 sessions of this non invasive treatment should be spaced 30 days apart to start seeing fantastic improvements to the quality of your skin.

What is SkinPen?

This revolution in scar management works by first creating low level trauma to the surface of the skin encouraging an immune response. The skin then heals and new dermal tissues and blood vessels form, remodeling the scar tissue to leave the skin smoother with improved texture and a reduction in visible scarring.

The first FDA cleared Microneedling device

TREATMENT TIME

40 minutes

DURATION

Permanent with maintenance

RETURN TO WORK IN

Same day

ANAESTHETIC

Topical anaesthetic

Frequently Asked Questions

The treatment can sting a little, but most patients adapt well to this sensation. Topical anaesthetic can be used, as well as a gel to work to eliminate friction during the treatment.

The face may be a little tender or sore post treatment. This is due to the micro trauma created during application. The science behind this treatment is to create light trauma to the skin to cause an inflammatory, healing response. Any side effects will be discussed at your pre-treatment consultation.

We usually recommend starting your SkinPen plan with 3 treatments 30 days apart. Depending on how your skin responds and the size and severity of the area being treated, this can vary. We will put together a treatment plan to suit your needs, but following treatment you should expect to see a visible reduction in acne scarring. Maintenance treatments may be required to support and optimise your result.

SkinPen is the first microneedling treatment for acne scarring to have received FDA clearance. SkinPen themselves boast about their safety record, part of which includes the use of a BioShield to prevent cross contamination between treatments.